Stocks
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -175.2 | -179.4 | -189.3 | -128.8 | -29.8 | -22.0 | ||
| Changes by years, y/y, % | -9% | +2% | +6% | -32% | -77% | -27.0% | |||
Adaptive Biotechnologies. EBITDA US GAAP, bln rub
Adaptive Biotechnologies. EBITDA US GAAP, changes, %
Adaptive Biotechnologies. EBITDA US GAAP, sum by quarters, bln rub
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -29.6 | -18.1 | 16.9 | -6.43 | -14.4 | -22.0 | |
| Changes by years, y/y, % | -25% | -53% | -169% | -76% | -51% | |||
| Changes by quarters, q/q, % | +12% | -39% | -193% | -138% | +124% | |||
